On demand | How should employers approach weight loss drugs?
Thank you for your interest in our event. Unfortunately, this webinar has passed. If you would like to watch a recording of the session, please click the link below.
GLP-1 agonists, used for managing type 2 diabetes and promoting weight loss, are experiencing growing interest among businesses. New trends bring new questions. How effective are these drugs? And what do employers need to consider before adding them to their formulary?
Join us for a panel discussion about the decisions employers must make with the introduction of drugs like Ozempic and Wegovy. In this webinar, we’ll discuss the pros and cons of GLP-1s from an employer’s perspective and best practices for adding them to your formulary.
Date: April 9, 2024
Time: 2 pm, ET
Duration: 57 minutes
Speakers: Kate Moher, President, National Employee Health & Benefits
Dr. Heidi Orstad, PATH Clinical Consultant
Rick Kelly, FSA, Pharmacy Practice Leader
Malissa D. Moss, RN, MSN, CCM , PATH Clinical Consultant
If you’d like to connect with a local MMA consultant to learn more about this topic, please click here.
